DrugPatentWatch Database Preview
HISTAFED Drug Profile
Which patents cover Histafed, and when can generic versions of Histafed launch?
The generic ingredient in HISTAFED is pseudoephedrine hydrochloride; triprolidine hydrochloride. There are forty-nine drug master file entries for this compound. Additional details are available on the pseudoephedrine hydrochloride; triprolidine hydrochloride profile page.
Summary for HISTAFED
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Bulk Api Vendors: | 14 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | see details |
| DailyMed Link: | HISTAFED at DailyMed |
US Patents and Regulatory Information for HISTAFED
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cenci | HISTAFED | pseudoephedrine hydrochloride; triprolidine hydrochloride | SYRUP;ORAL | 088283-001 | Apr 20, 1984 | DISCN | No | No | ➤ Try a Free Trial | ➤ Try a Free Trial | ➤ Try a Free Trial | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
